6-Chloroguanine

6-Chloroguanine

SCHEMBL12813171

Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)nc1N.Nc1nc(Cl)c2[nH]cnc2n1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.49
▸ MTOR P42345 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ GMNN O75496 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ DNMT1 P26358 1/20 0.49
▸ THPO P40225 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ HBB P68871 1/20 0.49
▸ PMP22 Q01453 1/20 0.49
▸ THRB P10828 1/20 0.45
▸ MDM2 Q00987 1/20 0.45
▸ NCOA1 Q15788 1/20 0.45
▸ NCOA3 Q9Y6Q9 1/20 0.45
▸ DPP4 P27487 1/20 0.44
▸ PYGM P11217 1/20 0.42
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
6-Chloroguanine SCHEMBL12813167 0.86 LMNA (0.49) LMNAMTORTP53GMNNALDH1A1
SCHEMBL5697581 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL5953706 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL14929291 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL14441083 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL2579580 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL41572 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL18512948 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL5953287 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1
SCHEMBL6297856 0.83 LMNA (0.62) LMNAMTORTP53GMNNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797634-A1 MODIFIED MRNAS ENCODING CELL-PENETRATING POLYPEPTIDES Moderna Therapeutics, Inc. (US) 2014-11-05 — — EP disclosed
EP-2691101-A2 DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS Moderna Therapeutics, Inc. (US) 2014-02-05 — — EP disclosed
WO-2013101690-A1 MODIFIED MRNAS ENCODING CELL-PENETRATING POLYPEPTIDES modeRNA Therapeutics (US) 2013-07-04 — — WO disclosed
WO-2012135805-A2 DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS modeRNA Therapeutics (US) 2012-10-04 — — WO disclosed
Send feedback